Spring 2020 Meeting

See tabs below for links that were previously here.

Horizontal Tabs

Meeting Information-2020S

The GCIG Spring 2020 meeting will be held virtually May 20 - June 13, 2020. 

Meeting Letter
Virtual Meeting Guidelines
GCIG Trial Presentation Guidelines
Information Sheet with Useful Links for the COVID-19 Pandemic in Cancer Practice and Clinical Trials

Full Meeting Schedule
All meetings will commence at 8:00 EDT.

Date Committee/Working Group
Wednesday, May 20, 2020 Communications Working Group 
Tuesday, May 26, 2020 Phase II Committee 
Tuesday, May 26, 2020 Nominations Working Group* 
Wednesday, May 27, 2020 CCRN
Thursday, May 28, 2020 Education Committee
Friday, May 29, 2020 Rare Tumour Committee
Saturday, May 30, 2020 Meta-Analysis Committee
Sunday, May 31, 2020 Harm Stats
Monday, June 1, 2020 Cervix Cancer Committee
Tuesday, June 2, 2020 Endometrial Cancer Committee
Wednesday, June 3, 2020 Ovarian Cancer Committee
Thursday, June 4, 2020 Harm Ops Committee
Friday, June 5, 2020 Translational Research Committee
Saturday, June 6, 2020 Symptom Benefit Committee
Saturday, June 6, 2020 GCIG Virtual Maggiano's**
Monday, June 8, 2020 6th OCCC (CLOSED)
Tuesday, June 9, 2020 Membership (CLOSED)
Wednesday, June 10, 2020 Finance (CLOSED)
Saturday, June 13, 2020 General Assembly (LIMITED)

*The Nominations Working Group meeting will directly follow the Phase II Committee meeting.

**Virtual Maggiano's gathering on Saturday, June 6, 2020 at 9:30 AM EDT, following the Symptom Benefit Committee meeting.  Please bring your favorite beverage (this will of course vary depending on your time zone). 

Communications Working Group-2020S

Communications Working Group

Phase II Committee-2020S

Phase II Committee

Nominations/Meeting Working Group-2020S

Nominations/Meeting Working Group

CCRN-2020S
Education Committee/GREAT Task Force-2020S

Education Committee/GREAT Task Force

Rare Tumour Committee-2020S

Rare Tumour Committee

Meta-Analysis Working Group-2020S

Meta-Analysis Working Group

Harm Stats Committee-2020S

Harm Stats Committee

Cervix Cancer Committee-2020S

Cervix Cancer Committee

Endometrial Cancer Committee-2020S

Endometrial Cancer Committee

Ovarian Cancer Committee-2020S

Ovarian Cancer Committee

Harm Ops Committee-2020S

Harm Ops Committee

Translational Research Committee-2020S

Translational Research Committee

Symptom Benefit Committee-2020S

Symptom Benefit Committee

General Assembly-2020S

General Assembly